Expert Opin Pharmacother
-
Publication Venue For
- Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction.. 21:1851-1865. 2020
- Cangrelor for the treatment of patients with Arterial Thrombosis.. 19:1389-1398. 2018
- Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments.. 19:653-665. 2018
- Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations.. 19:451-456. 2018
- Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?. 18:1417-1420. 2017
- Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?. 18:487-495. 2017
- Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.. 18:123-131. 2017
- Adjunctive brexpiprazole for the treatment of major depressive disorder.. 17:2331-2339. 2016
- P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.. 16:1149-1165. 2015
- Advances in the treatment of invasive neonatal candidiasis.. 16:1035-1048. 2015
- Oritavancin for acute bacterial skin and skin structure infections.. 16:1091-1098. 2015
- Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States.. 16:805-819. 2015
- Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer.. 16:473-485. 2015
- Resistance to antiplatelet drugs: what progress has been made?. 15:2553-2564. 2014
- Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens.. 15:2047-2061. 2014
- Recent advances in the treatment of life-threatening, invasive fungal infections.. 14:2361-2374. 2013
- Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.. 14:1529-1536. 2013
- Trametinib (GSK1120212) in the treatment of melanoma.. 14:619-627. 2013
- Everolimus in colorectal cancer.. 14:505-513. 2013
- Importance of potent P2Y(12) receptor blockade in acute myocardial infarction: focus on prasugrel.. 13:1771-1796. 2012
- Adefovir dipivoxil in chronic hepatitis B: history and current uses.. 13:245-254. 2012
- Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.. 12:2737-2750. 2011
- Everolimus tablets for patients with subependymal giant cell astrocytoma.. 12:2265-2269. 2011
- Review of the use of mirtazapine in the treatment of depression.. 12:1623-1632. 2011
- Strategies to manage antifungal drug resistance.. 12:241-256. 2011
- Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.. 12:85-98. 2011
- Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.. 11:2907-2913. 2010
- Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure.. 11:2405-2415. 2010
- Pharmacogenetics of toxic epidermal necrolysis.. 11:2153-2162. 2010
- Ticagrelor for the treatment of arterial thrombosis.. 11:2251-2259. 2010
- Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.. 10:1561-1570. 2009
- Mycophenolate mofetil in myasthenia gravis: the unanswered question.. 9:2545-2551. 2008
- Major bleeding: management and risk reduction in acute coronary syndromes.. 9:1869-1883. 2008
- Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies.. 8:1861-1870. 2007
- Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder.. 8:745-758. 2007
- Pharmacological strategies for the prevention of Alzheimer's disease.. 7:1-10. 2006
- Combining cancer vaccines with chemotherapy.. 6:2813-2820. 2005
- Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directions.. 6:2617-2632. 2005
- Resistance to antiplatelet drugs: current status and future research.. 6:2027-2045. 2005
- Echinocandins: role in antifungal therapy, 2005.. 6:1657-1668. 2005
- Neonatal candidiasis: prophylaxis and treatment.. 6:1647-1655. 2005
- Decision models for assessing the cost effectiveness of drug-eluting stents.. 6:965-974. 2005
- Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.. 6:1003-1018. 2005
- Paroxetine in the treatment of generalised anxiety disorder.. 5:1799-1806. 2004